Tenofovir exalidex (BioDeep_00000837876)
代谢物信息卡片
化学式: C28H52N5O5P (569.3705871999999)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)O
InChI: InChI=1S/C28H52N5O5P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-36-19-17-20-38-39(34,35)24-37-25(2)21-33-23-32-26-27(29)30-22-31-28(26)33/h22-23,25H,3-21,24H2,1-2H3,(H,34,35)(H2,29,30,31)/t25-/m1/s1
描述信息
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents
C254 - Anti-Infective Agent > C281 - Antiviral Agent
同义名列表
1 个代谢物同义名
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Thuy Hoang, Abhijit A Date, Jairo Ortiz Ortiz, Ting-Wei Young, Sabrine Bensouda, Peng Xiao, Mark Marzinke, Lisa Rohan, Edward J Fuchs, Craig Hendrix, Sanjeev Gumber, Francois Villinger, Richard A Cone, Justin Hanes, Laura M Ensign. Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
2019 May; 138(?):23-29. doi:
10.1016/j.ejpb.2018.05.030. [PMID: 29802984] - Pamela Hummert, Teresa L Parsons, Laura M Ensign, Thuy Hoang, Mark A Marzinke. Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs.
Journal of pharmaceutical and biomedical analysis.
2018 Apr; 152(?):248-256. doi:
10.1016/j.jpba.2018.02.011. [PMID: 29433097] - Kyle E Giesler, Jose Marengo, Dennis C Liotta. Reduction Sensitive Lipid Conjugates of Tenofovir: Synthesis, Stability, and Antiviral Activity.
Journal of medicinal chemistry.
2016 08; 59(15):7097-110. doi:
10.1021/acs.jmedchem.6b00428. [PMID: 27405794] - E Randall Lanier, Roger G Ptak, Bernhard M Lampert, Laurie Keilholz, Tracy Hartman, Robert W Buckheit, Marie K Mankowski, Mark C Osterling, Merrick R Almond, George R Painter. Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV.
Antimicrobial agents and chemotherapy.
2010 Jul; 54(7):2901-9. doi:
10.1128/aac.00068-10. [PMID: 20439609] - George R Painter, Merrick R Almond, Lawrence C Trost, Bernhard M Lampert, Johan Neyts, Erik De Clercq, Brent E Korba, Kathy A Aldern, James R Beadle, Karl Y Hostetler. Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections.
Antimicrobial agents and chemotherapy.
2007 Oct; 51(10):3505-9. doi:
10.1128/aac.00460-07. [PMID: 17646420]